|
Post by joeypotsandpans on Oct 4, 2018 4:41:01 GMT -5
His latest: seekingalpha.com/article/4209761-mannkind-better-r-and-d-company-full-service-pharma-companyMK's response: Michael Kovacocy • 3rd Capital Markets Macro and Micro; Capital Sourcing; Bitcoin and Cryptocurrencies OTC and Trading Advisory; Media Contributor 2h MNKD - I read an article where a certain person who has myopically focused on Afrezza, suddenly sees an R&D company and the need to hive off Afrezza on the cheap...You just don’t stop, do ya?... The smart thing for management to do is to ramp Afrezza sales and make it a winner now that money is coming in from places that this myopic writer never talked of. Make Afrezza a winner and bury these nuisances. Then if you do sell much later, you are selling a winner and the hacks can’t buy themselves a dinner. hashtag#MNKD For anyone that attended the shareholder's meeting, this was addressed back then in May by Mike as he acknowledged exactly what MK states, that Afrezza is the flagship of the company and the future backbone of the company. As an aside, rumor has it that Spiro has recently started accumulating shares again now that he is confident MNKD has secured a runway as far as the eyes can see for continuing their manufacturing of his Afrezza. I guess Spiro is just one of those sponges I mentioned soaking up/absorbing some of those "musical shares"
|
|
|
Post by sportsrancho on Oct 4, 2018 14:57:39 GMT -5
Ha ha, I heard that rumor also...in fact somebody tweeted it to me on Twitter, “Did you hear.......?” I said, Yep already heard:-)) It’s hard to explain how bullish that is, but it just is!
|
|
|
Post by akemp3000 on Oct 4, 2018 15:31:44 GMT -5
The ego of SO to seriously believe he has the superior intellect to advise Mike Castagna is nothing short of priceless. Am so enjoying watching Mike's turnaround of this company play out.
|
|
|
Post by sportsrancho on Oct 4, 2018 16:18:45 GMT -5
I believe Afrezza will be fine and there’s no way Mike is giving up on it he knows where the tipping point is. What is it they say, never tell a man how to run his own business! With that being said I think this is Spencer’s most bullish article to date. Even though I don’t agree with the Afrezza portion I think he said some very bullish things about TS here’s one of the comments.
When the bears turn against you Spence, it's a contrarian success. I'm not an "Afrezza-Army' guy but, I believe, like you that it has the potential in the hands of the right company that wants to make a deal that MNKD shareholders could approve. This is the first time I fully agree with you as a long. Their proprietary delivery system and ability to make various compounds to deliver many drugs effectively through their delivery system is a winner! The UTH model is a solid base from which to begin this massive turn around story. LOL, now the bears are arguing with Spence! That's telling. Best regards.
|
|